0000899243-18-006100.txt : 20180302
0000899243-18-006100.hdr.sgml : 20180302
20180302161559
ACCESSION NUMBER: 0000899243-18-006100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180301
FILED AS OF DATE: 20180302
DATE AS OF CHANGE: 20180302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hooks Corwin Dale
CENTRAL INDEX KEY: 0001665347
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35347
FILM NUMBER: 18662165
MAIL ADDRESS:
STREET 1: C/O CLOVIS ONCOLOGY, INC.
STREET 2: 5500 FLATIRON PARKWAY
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (303) 625-5000
MAIL ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-01
0
0001466301
Clovis Oncology, Inc.
CLVS
0001665347
Hooks Corwin Dale
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY, SUITE 100
BOULDER
CO
80301
0
1
0
0
See Remarks
Common Stock
2018-03-01
4
M
0
869
A
3556
D
Common Stock
2018-03-01
4
F
0
467
55.51
D
3089
D
Restricted Stock Units
2018-03-01
4
M
0
869
0.00
D
Common Stock
869
8688
D
Each Restricted Stock Unit represents the right to receive one share of Common Stock.
On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
Senior Vice President and Chief Commercial Officer
/s/ Dale Corwin Hooks
2018-03-02